Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy

Intravitreal injections of anti-vascular endothelial growth factor agents such as ranibizumab and aflibercept are the first-line treatment for neovascular age-related macular degeneration (AMD). However, data about long-term outcome in real-world clinical practice is scarce. We recruited 98 AMD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Keiichi, Oishi, Akio, Hata, Masayuki, Miyake, Masahiro, Ooto, Sotaro, Yamashiro, Kenji, Miyata, Manabu, Tamura, Hiroshi, Ueda-Arakawa, Naoko, Takahashi, Ayako, Kawashima, Yu, Tsujikawa, Akitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403223/
https://www.ncbi.nlm.nih.gov/pubmed/30842468
http://dx.doi.org/10.1038/s41598-019-39995-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403223/
https://www.ncbi.nlm.nih.gov/pubmed/30842468
http://dx.doi.org/10.1038/s41598-019-39995-5

Ejemplares similares